tmrFebruary 18, 2021
Rare Neurodegenerative Disease Treatment Market – Scope of the Report
TMR’s report on the global rare neurodegenerative disease treatment market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global rare neurodegenerative disease treatment market for the period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global rare neurodegenerative disease treatment market for the same period.
The report has been prepared after extensive research. Primary research involves a bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to unders
tmrFebruary 18, 2021
Transparency Market Research (TMR) observes that the
global leather chemicals market is highly competitive owing to the presence of a number of players operating in the global market. Some of the prominent players operating in the global leather chemicals market are Wei Tai Leather Co. Ltd., BASF SE, DyStar Singapore Pte Ltd. Clariant International Ltd., and Rock Chemie Co. In order to remain dominant in the global market for leather chemicals, these players are increasingly taking part into strategies such as a merger, acquisition, and partnerships. Additionally, numerous new entrants are struggling to enter into the market. Vendors in the leather chemical are trying to develop innovative and more eco-friendly products.
tmrFebruary 18, 2021 5
Transcatheter heart valve implantation is a procedure with less invasive approach helps in replacing the heart valve with prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. It is the effective alternative to cumbersome open heart surgery especially for high risk patients. The procedure helps reduce severe degenerative aortic stenosis and increases survival rate of patients. Increasing percutaneous transcatheter prosthetic valve implantation worldwide is expected to drive demand for transcatheter heart valve devices, as risk of valvular heart disease is higher among geriatric population, owing to increasing prevalence of severe aortic stenosis and asymptomatic severe mitral regurgitation.